Solventum Launches Attest™ eBowie-Dick Test System Revolutionizing Sterilization Assurance
Solventum Co. (NYSE: SOLV) had its price target raised by analysts at Morgan Stanley from $73.00 to $80.00. They now have an "equal weight" rating on the stock.
Solventum Co. (NYSE: SOLV) had its price target raised by analysts at Mizuho from $70.00 to $82.00. They now have a "neutral" rating on the stock.
Solventum Co. (NYSE: SOLV) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $63.00 to $71.00. They now have a "sell" rating on the stock.
Solventum Co. (NYSE: SOLV) had its price target raised by analysts at Wells Fargo & Company from $73.00 to $75.00. They now have an "equal weight" rating on the stock.